Outpatient (ex Primary Care)


Interview: Sam Gray, Apposite Capital

London-based PE group Apposite Capital is among the most active investors in health care in Europe. HBI chats with managing partner Sam Gray about the state of the market and pricing, how he sees that changing, and the investment opportunities piquing his interest at present.

Legal challenges may derail German investor crackdown

HBI hears German health minister Karl Lauterbach’s plan to stop “locust investors” from buying up outpatient facilities may be shot down by a double whammy of legal and political considerations. HBI speaks to a Germany-based lawyer and healthcare expert to find out more.

Good growth but profit problems for Terveystalo and Attendo in 2022

Elderly care group Attendo and outpatient group Terveystalo, two pan-Nordic giants with over a billion in revenue, struggled to turn a profit in 2022. This was despite strong (organic) revenue growth, set against a backdrop of rising inflation. HBI looks at the newly released results of both groups to find out more. 

Saudi boom creating billion dollar opportunities

Sources at the Arab Health exhibition confirm that the ambitious Saudi 2030 project which will see the country transfer most health care service delivery to the for-profit sector is still on. What are the implications of this?

German reforms “could kill PE outpatient investment”

German health minister Karl Lauterbach offered a politicised Christmas present in December with an announcement he would stop “locust investors” buying up outpatient medical practices. A German VC source tells HBI this could “kill” private equity investment in German healthcare, and push innovation elsewhere.

Pressure grows to restrict investment in German health care

Pressure is growing for a change in German law restricting who can invest in healthcare. If enacted, it could effectively see some outpatient operators “banned”, and restrict who can do telehealth. Is such a development likely? HBI speaks to a trio of German healthcare experts to find out more.

Chris Toth, CEO, Varian, a Siemens Healthineers Company

In April last year, medical device giant Siemens Healthineers acquired Varian Medical Systems in one of the largest all cash MedTech transactions in history. HBI catches up with Varian CEO Chris Toth to find out more about the deal, and Varian’s plans for the future. 

Scanmed buys Ars Medical

Polish multi-specialty healthcare company Scanmed has bought Polish oncology firm Ars Medical.

Find Us